Vor Biopharma Inc.
VOR
$2.17
-$0.03-1.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,309.41% | 1.36% | 0.81% | 2.64% | -11.29% |
| Total Depreciation and Amortization | 27.27% | -5.23% | 1.03% | 9.99% | 87.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12,248.14% | 3.85% | 2.17% | -20.22% | -33.70% |
| Change in Net Operating Assets | 311.79% | 153.24% | -99.23% | -334.64% | -768.36% |
| Cash from Operations | -8.98% | 5.85% | 0.63% | -5.30% | -21.75% |
| Capital Expenditure | 30.04% | 68.23% | 78.58% | 79.05% | 37.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -51.63% | 34.70% | 406.50% | 335.45% |
| Cash from Investing | -99.79% | -51.46% | 36.40% | 394.98% | 330.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7,436.98% | 3,658.22% | 1,057.58% | -99.61% | -99.39% |
| Repurchase of Common Stock | 60.63% | 78.74% | 71.95% | 72.10% | 49.74% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -224.27% | 100.00% | 100.00% |
| Cash from Financing | 85,533.83% | 10,131.07% | 1,717.29% | -99.89% | -99.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.03% | 102.59% | 292.02% | 149.19% | 242.69% |